statistiche ricercatore

Continente	#
NA - Nord America	1.417
EU - Europa	719
AS - Asia	537
SA - Sud America	114
Continente sconosciuto - Info sul continente non disponibili	22
AF - Africa	14
OC - Oceania	2
Totale	2.825

Nazione	#
US - Stati Uniti d'America	1.346
RU - Federazione Russa	270
SG - Singapore	148
CN - Cina	139
IT - Italia	126
BR - Brasile	98
GR - Grecia	87
VN - Vietnam	83
CA - Canada	64
SE - Svezia	48
DE - Germania	36
BD - Bangladesh	33
IE - Irlanda	33
FR - Francia	31
JP - Giappone	28
KR - Corea	27
GB - Regno Unito	22
FI - Finlandia	21
HK - Hong Kong	19
IN - India	16
TR - Turchia	12
ES - Italia	9
NL - Olanda	9
ID - Indonesia	7
UA - Ucraina	7
AR - Argentina	6
AT - Austria	6
TW - Taiwan	6
CH - Svizzera	5
IR - Iran	5
MX - Messico	3
PK - Pakistan	3
PL - Polonia	3
UY - Uruguay	3
ZA - Sudafrica	3
AU - Australia	2
CI - Costa d'Avorio	2
CL - Cile	2
DK - Danimarca	2
DZ - Algeria	2
IS - Islanda	2
KZ - Kazakistan	2
MA - Marocco	2
PH - Filippine	2
TH - Thailandia	2
UG - Uganda	2
BO - Bolivia	1
BY - Bielorussia	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
EC - Ecuador	1
GM - Gambi	1
GT - Guatemala	1
IL - Israele	1
IQ - Iraq	1
JM - Giamaica	1
KE - Kenya	1
KG - Kirghizistan	1
NG - Nigeria	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
PY - Paraguay	1
RS - Serbia	1
TT - Trinidad e Tobago	1
VE - Venezuela	1
Totale	2.804

Nome	#
An engineering oriented approach to physiologically based pharmacokinetic and pharmacodynamic modeling	266
A new approach for pharmacokinetic model application towards personalized medicine	231
Engineering approaches in siRNA delivery	221
Definition and validation of a patient-individualized physiologically-based pharmacokinetic model	207
PHARMACOKINETICS OF REMIFENTANIL: METABOLISM AND MODELING	201
Innovations and improvements in pharmacokinetic models based on physiology	198
A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of remifentanil	184
A modeling tool for the personalization of pharmacokinetic predictions	181
A physiologically based model for tramadol pharmacokinetics in horses	176
Performance of classical and physiologically-based PK-PD modelling for prediction of remifentanil hemodynamic effects	171
A PSE approach to patient-individualized physiologically-based pharmacokinetic modeling	169
Enterohepatic Circulation Effect in Physiologically Based Pharmacokinetic Models: The Sorafenib Case	166
Chemical engineering in the “BIO” world	161
Sorafenib in mice - A Pharmacokinetic study	152
MASS BALANCE: AN OLD CONCEPT FOR THE NEW CHALLENGES PROPOSED BY PERSONALIZED MEDICINE	141
Totale	2.825

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	125	0	0	0	19	32	8	7	11	3	8	13	24
2022/2023	163	29	2	4	2	24	25	1	9	29	12	19	7
2023/2024	119	4	25	3	15	6	37	1	3	2	5	3	15
2024/2025	334	2	1	31	25	40	35	9	35	31	31	65	29
2025/2026	1.181	215	202	51	89	72	78	136	60	78	77	48	75
2026/2027	119	14	21	46	38	0	0	0	0	0	0	0	0
Totale													2.825

RE.PUBLIC@POLIMI pubblicazioni di ricerca del Politecnico di Milano